BreezeBio Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
BreezeBio is a biotechnology company focused on precision genetic medicines delivered via targeted non-viral delivery to biologically relevant tissues. The company uses its NanoGalaxy platform to engineer nanoparticles that deliver genetic payloads, including mRNA, to specific cell types, with demonstrated delivery to immune cells and to tissues in the heart, lung, and central nervous system. BreezeBio maintains an internal therapeutic pipeline focused on autoimmune diseases and oncology, with lead program BRZ-101 designed to restore immune tolerance in type 1 diabetes and advancing into IND-enabling studies. It is headquartered in the South San Francisco area, with an address at 3000 Marina Boulevard, 350 Marina, California, United States, and employs between 51 and 200 people. In 2026, BreezeBio announced financing and partnerships, including a $60 million Series B and a collaboration with Genentech.
1-888-653-2347 
support@leadiq.com 
